Filing Details
Moderna, Inc. (NASDAQ:MRNA) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:MRNA
Moderna, Inc. (MRNA) Reports Material Event to SEC
Filing Details Moderna, Inc. (NASDAQ:MRNA) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context Moderna,…
Market Context
Moderna, Inc.'s stock currently trades at $73.80 with a market capitalization of $11.6B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Moderna, Inc.'s stock.
All SEC filings for Moderna, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MRNA Stock Page
Frequently Asked Questions
Where can I read MRNA's SEC filings?
Browse all filings on our MRNA SEC filings page.
What types of SEC filings does Moderna, Inc. file?
Public companies like Moderna, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
